These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1833172)

  • 21. [Mechanism of prolonged hypocoagulation appearing after intratracheal administration of heparin].
    Efimov VS; Rumiantseva AG; Golovleva OA; Rozkin MIa
    Biull Eksp Biol Med; 1992 May; 113(5):509-12. PubMed ID: 1421273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isolation and characterization of heparin from tuna skins.
    Jeske WP; McDonald MK; Hoppensteadt DA; Bau EC; Mendes A; Dietrich CP; Walenga JM; Coyne E
    Clin Appl Thromb Hemost; 2007 Apr; 13(2):137-45. PubMed ID: 17456622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Influence of Echis carinata venom on hemostasis].
    Zimmermann H; Habermann E; Lasch HG
    Thromb Diath Haemorrh; 1971 Jun; 25(3):425-37. PubMed ID: 5561955
    [No Abstract]   [Full Text] [Related]  

  • 24. Slight differences in sulfation of algal galactans account for differences in their anticoagulant and venous antithrombotic activities.
    Fonseca RJ; Oliveira SN; Melo FR; Pereira MG; Benevides NM; Mourão PA
    Thromb Haemost; 2008 Mar; 99(3):539-45. PubMed ID: 18327402
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of new synthetic heparin mimetics on whole blood thrombin generation in vivo and in vitro in rats.
    Hérault JP; Bernat A; Gaich C; Herbert M
    Thromb Haemost; 2002 Feb; 87(2):238-44. PubMed ID: 11858483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In-vitro efficacy of different platelet glycoprotein IIb/IIIa antagonists and thrombolytics on platelet/fibrin-mediated clot dynamics in human whole blood using thrombelastography.
    Mousa SA
    Blood Coagul Fibrinolysis; 2007 Jan; 18(1):55-60. PubMed ID: 17179828
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Use of the thromboelastograph for registration of the time of euglobulin lysis in normal rats and those with experimentally modified fibrinolysis].
    Prino G; Mantovani M; Butti A
    Farmaco Prat; 1969 Sep; 24(9):552-61. PubMed ID: 4187112
    [No Abstract]   [Full Text] [Related]  

  • 28. [Influence of nonachlazin, riboxin and isoptin on the blood coagulation system and the anticoagulant effect of heparin].
    Shevchenko LV; Ovchinnikova LK; Zolotukhin SI
    Farmakol Toksikol; 1980; 43(4):389-95. PubMed ID: 7439373
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fucosylated chondroitin sulfate as a new oral antithrombotic agent.
    Fonseca RJ; Mourão PA
    Thromb Haemost; 2006 Dec; 96(6):822-9. PubMed ID: 17139379
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contact product in experimental intravascular activation of the clotting system.
    Altman R; Rouvier J; Daldin J
    Rev Bras Pesqui Med Biol; 1973; 6(5):223-8. PubMed ID: 4774622
    [No Abstract]   [Full Text] [Related]  

  • 31. Drugs and herbal remedies that affect blood clotting.
    Wynn RL; Bergman SA
    Gen Dent; 2002; 50(6):484-8, 490. PubMed ID: 12572177
    [No Abstract]   [Full Text] [Related]  

  • 32. Thrombin-activated thrombelastography for evaluation of thrombin interaction with thrombin inhibitors.
    Taketomi T; Szlam F; Vinten-Johansen J; Levy JH; Tanaka KA
    Blood Coagul Fibrinolysis; 2007 Dec; 18(8):761-7. PubMed ID: 17982317
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Principles of the treatment of hypercoagulabilities with a rational anticoagulant therapy].
    Raby C
    Presse Med (1893); 1969 Jan; 77(1):17-9. PubMed ID: 5785756
    [No Abstract]   [Full Text] [Related]  

  • 34. Pravastatin potentiates the anticoagulant effects of low molecular weight heparin.
    Zimmer JE; Spillert CR; Puppala S; Zamecki K; Bhatt BA; Arora RR
    Thromb Res; 2004; 113(6):407-10. PubMed ID: 15226096
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of protease inhibitor (trasylol) and heparin in cardiorespiratory resuscitation. I. Studies of the blood clotting system.
    Gaszyński W
    Anaesth Resusc Intensive Ther; 1975; 3(2):125-34. PubMed ID: 1080969
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemical approaches to define the structure-activity relationship of heparin-like glycosaminoglycans.
    Noti C; Seeberger PH
    Chem Biol; 2005 Jul; 12(7):731-56. PubMed ID: 16039522
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influences of earthworm extract G-90 on haematological and haemostatic parameters in Wistar rats.
    Matausic-Pisl M; Tomicic M; Micek V; Grdisa M
    Eur Rev Med Pharmacol Sci; 2011 Jan; 15(1):71-8. PubMed ID: 21381501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The influence of the Soviet antimalarial preparation dabequin on the hemostatic system and on the anticoagulant effect of heparin].
    Pomortseva IV; Ovchinnikova LK; Shcheglova NV
    Farmakol Toksikol; 1990; 53(1):59-62. PubMed ID: 2328805
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparative study of the effects of 4-chlorophenyl-2-hydroxy-4-oxo-2-butenoate and heparin on blood coagulation].
    Starkova AV; Sobin FB; Syropiatov BIa; Pulina NA
    Eksp Klin Farmakol; 2013; 76(10):25-6. PubMed ID: 24400385
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Fundamental principles of hemostasis--oral antiplatelets and anticoagulants].
    Morais D; Maranda G
    J Dent Que; 1987 Apr; 24():201-7. PubMed ID: 3298345
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.